Accuracy of Machine Learning Algorithms for the Classification of Molecular Features of Gliomas on MRI: A Systematic Literature Review and Meta-Analysis.
Evi J van KempenMax PostManoj MannilBenno KustersMark ter LaanFrederick J A MeijerDylan Jozef Hendrik Augustinus HenssenPublished in: Cancers (2021)
Treatment planning and prognosis in glioma treatment are based on the classification into low- and high-grade oligodendroglioma or astrocytoma, which is mainly based on molecular characteristics (IDH1/2- and 1p/19q codeletion status). It would be of great value if this classification could be made reliably before surgery, without biopsy. Machine learning algorithms (MLAs) could play a role in achieving this by enabling glioma characterization on magnetic resonance imaging (MRI) data without invasive tissue sampling. The aim of this study is to provide a performance evaluation and meta-analysis of various MLAs for glioma characterization. Systematic literature search and meta-analysis were performed on the aggregated data, after which subgroup analyses for several target conditions were conducted. This study is registered with PROSPERO, CRD42020191033. We identified 724 studies; 60 and 17 studies were eligible to be included in the systematic review and meta-analysis, respectively. Meta-analysis showed excellent accuracy for all subgroups, with the classification of 1p/19q codeletion status scoring significantly poorer than other subgroups (AUC: 0.748, p = 0.132). There was considerable heterogeneity among some of the included studies. Although promising results were found with regard to the ability of MLA-tools to be used for the non-invasive classification of gliomas, large-scale, prospective trials with external validation are warranted in the future.
Keyphrases
- machine learning
- high grade
- deep learning
- big data
- magnetic resonance imaging
- artificial intelligence
- systematic review
- case control
- low grade
- contrast enhanced
- minimally invasive
- computed tomography
- electronic health record
- single cell
- diffusion weighted imaging
- clinical trial
- coronary artery bypass
- meta analyses
- phase iii
- magnetic resonance
- atrial fibrillation